These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


461 related items for PubMed ID: 17574422

  • 41. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3170-3. PubMed ID: 19435663
    [Abstract] [Full Text] [Related]

  • 42. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
    Gavernet L, Gonzalez Funes JL, Palestro PH, Bruno Blanch LE, Estiu GL, Maresca A, Barrios I, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1410-8. PubMed ID: 23266178
    [Abstract] [Full Text] [Related]

  • 43. Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
    Jaiswal M, Khadikar PV, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3283-90. PubMed ID: 15149691
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.
    Hen N, Bialer M, Yagen B, Maresca A, Aggarwal M, Robbins AH, McKenna R, Scozzafava A, Supuran CT.
    J Med Chem; 2011 Jun 09; 54(11):3977-81. PubMed ID: 21506569
    [Abstract] [Full Text] [Related]

  • 48. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY, Thiry A, Cheikh KE, Dogné JM, Montero JL, Vullo D, Scozzafava A, Masereel B, Supuran CT.
    Bioorg Med Chem Lett; 2007 May 15; 17(10):2685-91. PubMed ID: 17376683
    [Abstract] [Full Text] [Related]

  • 49. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK, Bano S, Supuran CT, Khadikar PV.
    Eur J Med Chem; 2004 Jul 15; 39(7):593-600. PubMed ID: 15236839
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety.
    Salmon AJ, Williams ML, Innocenti A, Vullo D, Supuran CT, Poulsen SA.
    Bioorg Med Chem Lett; 2007 Sep 15; 17(18):5032-5. PubMed ID: 17681760
    [Abstract] [Full Text] [Related]

  • 55. QSAR studies of sulfamate and sulfamide inhibitors targeting human carbonic anhydrase isozymes I, II, IX and XII.
    Tarko L, Supuran CT.
    Bioorg Med Chem; 2013 Mar 15; 21(6):1404-9. PubMed ID: 23206986
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2007 Jan 25; 50(2):381-8. PubMed ID: 17228881
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.